Perspective Therapeutics Stock Price on October 1, 2024
| CATX Stock | 3.47 0.47 15.67% |
Below is the normalized historical share price chart for Perspective Therapeutics extending back to November 05, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Perspective Therapeutics stands at 3.47, as last reported on the 25th of November, with the highest price reaching 3.59 and the lowest price hitting 2.94 during the day.
If you're considering investing in Perspective Stock, it is important to understand the factors that can impact its price. Perspective Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.24, which implies the firm had a -0.24% return per unit of risk over the last 3 months. Perspective Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Perspective Therapeutics' Coefficient Of Variation of (439.19), variance of 61.4, and Risk Adjusted Performance of (0.17) to confirm the risk estimate we provide.
At this time, Perspective Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 34.8 M in 2024, whereas Common Stock is likely to drop slightly above 103.4 K in 2024. . At this time, Perspective Therapeutics' Price To Sales Ratio is fairly stable compared to the past year. Price Sales Ratio is likely to rise to 57.93 in 2024, whereas Price Earnings Ratio is likely to drop (28.89) in 2024. Perspective Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of November 2005 | 200 Day MA 12.7391 | 50 Day MA 11.5164 | Beta 1.467 |
Perspective |
Sharpe Ratio = -0.2362
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CATX |
Estimated Market Risk
| 7.92 actual daily | 70 70% of assets are less volatile |
Expected Return
| -1.87 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.24 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Perspective Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Perspective Therapeutics by adding Perspective Therapeutics to a well-diversified portfolio.
Price Book 0.714 | Enterprise Value Ebitda (21.91) | Price Sales 150.6285 | Shares Float 43.5 M | Wall Street Target Price 18.1667 |
Related Headline
Sight Sciences Headline on 1st of October 2024
Filed transaction by Sight Sciences Officer: Chief Operating Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Perspective Therapeutics Valuation on October 1, 2024
It is possible to determine the worth of Perspective Therapeutics on a given historical date. On October 1, 2024 Perspective was worth 13.41 at the beginning of the trading date compared to the closed value of 12.63. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Perspective Therapeutics stock. Still, in general, we apply an absolute valuation method to find Perspective Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Perspective Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Perspective Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 12.70 | 13.43 | 12.50 | 13.35 | 1,118,168 | |
10/01/2024 | 13.41 | 13.44 | 12.40 | 12.63 | 1,049,986 |
| 12.83 | 13.39 | 12.55 | 13.21 | 1,289,916 |
| Backtest Perspective Therapeutics | | | Perspective Therapeutics History | | | Perspective Therapeutics Valuation | Previous | Next |
Perspective Therapeutics Trading Date Momentum on October 1, 2024
| On October 02 2024 Perspective Therapeutics was traded for 13.21 at the closing time. The top price for the day was 13.39 and the lowest listed price was 12.55 . The trading volume for the day was 1.3 M. The trading history from October 2, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 4.59% . The trading delta at closing time against the current closing price is 8.95% . |
Perspective Therapeutics Fundamentals Correlations and Trends
By evaluating Perspective Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Perspective Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Perspective financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Perspective Therapeutics Stock history
Perspective Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Perspective is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Perspective Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Perspective Therapeutics stock prices may prove useful in developing a viable investing in Perspective Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 28.2 M | 34.8 M | |
| Net Loss | -6.5 M | -6.9 M |
Perspective Therapeutics Quarterly Net Working Capital |
|
Perspective Therapeutics Stock Technical Analysis
Perspective Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Perspective Therapeutics Period Price Range
Low | November 25, 2024
| High |
0.00 | 0.00 |
Perspective Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NYSE MKT Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Perspective Therapeutics November 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Perspective Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Perspective Therapeutics shares will generate the highest return on investment. By undertsting and applying Perspective Therapeutics stock market strength indicators, traders can identify Perspective Therapeutics entry and exit signals to maximize returns
Perspective Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Perspective Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Perspective Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Perspective to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.17) | |||
| Jensen Alpha | (1.83) | |||
| Total Risk Alpha | (3.03) | |||
| Treynor Ratio | (6.21) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Perspective Stock Analysis
When running Perspective Therapeutics' price analysis, check to measure Perspective Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perspective Therapeutics is operating at the current time. Most of Perspective Therapeutics' value examination focuses on studying past and present price action to predict the probability of Perspective Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perspective Therapeutics' price. Additionally, you may evaluate how the addition of Perspective Therapeutics to your portfolios can decrease your overall portfolio volatility.